相关实验视频
Updated: Jan 9, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
877
超重和肥胖青少年的体重管理:当前的治疗方法
Liru Chen1, Xingyu Zhu2, Chengyu Liu3
1Department of Nutrition, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Asia Pacific journal of clinical nutrition
|December 3, 2025
概括
多元组件的生活方式干预是青少年肥胖的主要治疗方法. 建议将密集的健康行为生活方式治疗与抗肥胖药物结合起来,以有效地控制青少年的体重.
科学领域:
- 公共卫生 公共卫生
- 儿科 儿科 儿科
- 营养科学 营养科学
背景情况:
- 在全球范围内,青少年超重和肥胖的患病率正在上升.
- 青少年的肥胖会增加患心血管疾病等慢性疾病的风险.
- 青少年肥胖导致负面的健康结果,并使医疗保健系统承受压力.
研究的目的:
- 审查有关青少年体重管理策略的当前文献.
- 为了确定青少年肥胖的有效干预措施.
主要方法:
- 在PubMed和谷歌学者中进行文献搜索.
- 关键词包括:"超重"",肥胖"",青少年"",体重管理"",饮食管理"",营养干预".
- 布尔运算符"AND"和"OR"用于搜索精细化.
主要成果:
- 多元生活方式干预 (饮食,体力活动,行为) 是一线治疗.
- 节能饮食对于青少年的体重控制是有效的.
- 在能源限制期间,干预措施必须支持正常生长和发育.
结论:
- 多元组件的生活方式干预是青少年抗肥胖治疗的首选方法.
- 强烈的健康行为生活方式治疗与抗肥胖药物相结合,建议最初.
- 早期干预对于管理青少年肥胖至关重要.
相关概念视频
Binge Eating Disorders
403
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
403
Diabetes: Management and Pharmacotherapy
848
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
Drug Dosing: Obese Patients
202
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
202
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Insulin: Dosing Regimen and Adverse Effects
658
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
658

